Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Magnetite-Coated Cellulose Nanocrystals for Hyperthermia
2026-05-07
This study systematically investigates the self-assembly interactions and surface chemistry of magnetite-decorated cellulose nanocrystals (CNCs) for magnetic hyperthermia. Through detailed physicochemical and biocompatibility analyses, the work establishes structure–property relationships that inform the rational design of non-toxic, efficient nanocomposites for biomedical applications.
-
Zolmitriptan in Translational Migraine Research: Mechanisms
2026-05-07
This article explores Zolmitriptan’s mechanistic action as a 5-HT1B receptor agonist, its pivotal role in migraine and cluster headache research, and how advances in lysosomal biology can inform more nuanced experimental designs. Integrating recent insights into lysosomal modulation with strategic guidance, it guides translational researchers on optimizing protocols, benchmarking compound performance, and navigating the evolving intersection of serotonin receptor pharmacology and disease modeling.
-
LL-37 Peptide Fragments Combat MDR Acinetobacter baumannii B
2026-05-06
This study demonstrates that the human antimicrobial peptide LL-37 and its truncated fragments exhibit potent antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. The findings suggest new avenues for combating biofilm-associated infections, notably where traditional antibiotics face resistance barriers.
-
Tamsulosin (C6445): Evidence-Based Strategies for POUR Preve
2026-05-06
Explore how Tamsulosin, a selective α₁A-adrenergic receptor antagonist, transforms postoperative urinary retention (POUR) prevention and research. This article uniquely deciphers protocol design and clinical implications from the latest meta-analytic evidence, filling critical gaps in assay optimization.
-
Autophagic Degradation of FOXM1 Overcomes Chemoresistance
2026-05-05
This study identifies a novel small molecule, STL427944, which selectively targets the oncogenic transcription factor FOXM1 via autophagy-mediated degradation, sensitizing cancer cells to established chemotherapeutics, including taxanes. The research highlights a highly selective, mechanistically distinct approach to overcoming chemoresistance and provides a new framework for enhancing standard cancer chemotherapy outcomes.
-
Magnetite-Coated Cellulose Nanocrystals for Magnetic Hyperth
2026-05-05
This study elucidates how the surface chemistry of cellulose nanocrystals (CNCs) governs the assembly and functional performance of magnetite-CNC nanocomposites for magnetic hyperthermia. The findings establish quantitative links between interfacial bonding, magnetic properties, and biocompatibility, informing the rational design of safe and effective nanomaterials for biomedical applications.
-
Liproxstatin-1: Precision Ferroptosis Inhibition for Advance
2026-05-04
Liproxstatin-1 offers nanomolar potency and specificity for dissecting ferroptotic cell death, empowering researchers to unambiguously distinguish ferroptosis from other death modalities. Its robust performance in mammalian and emerging fungal ferroptosis models unlocks novel antifungal strategies and translational applications.
-
Chenodeoxycholic Acid: FXR-Driven Advances in Renal Research
2026-05-04
Harness the full translational impact of Chenodeoxycholic Acid (CDCA) by optimizing FXR activation protocols for cholesterol metabolism and kidney injury models. This article guides users from bench setup to troubleshooting, spotlighting the novel FXR/KLF11/JAK2-STAT3 axis and offering actionable parameters for robust, reproducible results.
-
Decitabine (5-Aza-2'-deoxycytidine): Unlocking Epigenetic Im
2026-05-03
Explore how Decitabine (5-Aza-2'-deoxycytidine) uniquely enhances anti-PD-1 immunotherapy by remodeling exhausted T cell populations. This in-depth article reveals mechanisms, protocol nuances, and practical implications for cancer epigenetics beyond standard tumor suppressor gene reactivation.
-
Toxicity of Sulfamonomethoxine Across Aquatic Trophic Levels
2026-05-02
This study provides a systematic evaluation of the acute and chronic toxicity of the sulfonamide antibiotic sulfamonomethoxine (SMM) in five representative aquatic species, spanning microalgae, cladocerans, and fish. The work clarifies organism-specific sensitivities and underscores the need for residue management in aquaculture to mitigate ecological impact.
-
LDH Cytotoxicity Assay Kit: Precision Cell Cytotoxicity Meas
2026-05-01
The LDH Cytotoxicity Assay Kit from APExBIO streamlines cell cytotoxicity measurement with a non-radioactive, sensitive platform ideal for applications from nanomaterial biocompatibility to apoptosis detection. Backed by recent advances in magnetic cellulose nanocrystal research, this kit offers robust data confidence and flexible protocol parameters for translational and discovery workflows.
-
EZ Cap™ Cre mRNA (m1Ψ): Optimized Gene Editing Workflows
2026-05-01
EZ Cap™ Cre mRNA (m1Ψ) delivers high-fidelity Cre recombinase expression with enhanced stability and minimal immunogenicity, redefining gene editing and functional studies. Its Cap 1 and m1Ψ modifications enable robust, reproducible workflows for both in vitro and in vivo applications.
-
Testosterone Bounce as a Prognostic Biomarker in Degarelix-T
2026-04-30
This study identifies 'testosterone bounce'—transient recovery of serum testosterone above 20 ng/dL after nadir—as a robust, independent predictor of overall and cancer-specific survival in prostate cancer patients treated with the GnRH antagonist degarelix. The findings suggest serum testosterone dynamics offer valuable prognostic information beyond standard PSA measures, informing patient monitoring and therapeutic strategies.
-
BMS 309403: Data-Driven Solutions for FABP4-Targeted Researc
2026-04-30
This article provides an evidence-based guide to BMS 309403 (SKU B7794) for researchers investigating FABP4 inhibition in lipid metabolism, inflammation, and atherosclerosis. Scenario-based Q&As address experimental design, data interpretation, and product selection, with actionable recommendations and protocol parameters. Leverage validated expertise on BMS 309403 to enhance reproducibility and assay reliability.
-
AptaBLE: Deep Learning for Aptamer-Protein Binding Predictio
2026-04-29
AptaBLE introduces a deep learning framework that significantly improves the prediction and design of aptamer-protein binding interactions, addressing longstanding limitations of SELEX and prior computational methods. This advance enables more accurate and rapid generation of high-affinity aptamers for research and therapeutic applications.